American International Group’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-44,180
Closed -$1.22M 1795
2024
Q1
$1.22M Buy
44,180
+325
+0.7% +$8.94K ﹤0.01% 1202
2023
Q4
$1.34M Sell
43,855
-176
-0.4% -$5.37K 0.01% 1156
2023
Q3
$1.39M Buy
44,031
+1,565
+4% +$49.5K 0.01% 1080
2023
Q2
$1.73M Buy
42,466
+2,457
+6% +$100K 0.01% 1010
2023
Q1
$1.49M Sell
40,009
-193
-0.5% -$7.19K 0.01% 1036
2022
Q4
$1.4M Buy
40,202
+4,402
+12% +$154K 0.01% 1059
2022
Q3
$2M Buy
35,800
+505
+1% +$28.3K 0.01% 932
2022
Q2
$1.83M Buy
35,295
+662
+2% +$34.3K 0.01% 971
2022
Q1
$2.52M Sell
34,633
-2,438
-7% -$177K 0.01% 951
2021
Q4
$4.38M Sell
37,071
-630
-2% -$74.5K 0.02% 842
2021
Q3
$5.06M Buy
37,701
+1,905
+5% +$256K 0.03% 780
2021
Q2
$5.8K Buy
35,796
+3,823
+12% +$619 0.02% 798
2021
Q1
$2.57K Buy
31,973
+2,845
+10% +$228 0.01% 1008
2020
Q4
$1.59K Sell
29,128
-836
-3% -$45 0.01% 1179
2020
Q3
$596K Buy
29,964
+3,158
+12% +$62.8K ﹤0.01% 1508
2020
Q2
$563K Buy
26,806
+3,920
+17% +$82.3K ﹤0.01% 1534
2020
Q1
$280K Sell
22,886
-1,323
-5% -$16.2K ﹤0.01% 1722
2019
Q4
$355K Sell
24,209
-203
-0.8% -$2.98K ﹤0.01% 1888
2019
Q3
$326K Buy
24,412
+1,263
+5% +$16.9K ﹤0.01% 1889
2019
Q2
$379K Buy
23,149
+1,962
+9% +$32.1K ﹤0.01% 1854
2019
Q1
$362K Sell
21,187
-687
-3% -$11.7K ﹤0.01% 1886
2018
Q4
$299K Sell
21,874
-168
-0.8% -$2.3K ﹤0.01% 1953
2018
Q3
$631K Buy
22,042
+397
+2% +$11.4K ﹤0.01% 1741
2018
Q2
$592K Buy
21,645
+10,991
+103% +$301K ﹤0.01% 1716
2018
Q1
$225K Sell
10,654
-573
-5% -$12.1K ﹤0.01% 2186
2017
Q4
$216K Buy
11,227
+1,718
+18% +$33.1K ﹤0.01% 2277
2017
Q3
$236K Buy
9,509
+711
+8% +$17.6K ﹤0.01% 2202
2017
Q2
$141K Buy
8,798
+4,503
+105% +$72.2K ﹤0.01% 2499
2017
Q1
$61K Buy
4,295
+281
+7% +$3.99K ﹤0.01% 2780
2016
Q4
$53K Sell
4,014
-12
-0.3% -$158 ﹤0.01% 2845
2016
Q3
$68.5K Buy
4,026
+6
+0.1% +$102 ﹤0.01% 2806
2016
Q2
$85.8K Buy
+4,020
New +$85.8K ﹤0.01% 2718